What Omics Empower does

Omics Empower is a Singapore-headquartered contract research organization (CRO) providing end-to-end single-cell sequencing, spatial transcriptomics, and yeast library screening services to academic researchers, pharmaceutical and biotechnology companies, and plant science investigators globally. The company operates laboratories in Berlin (Germany), Hong Kong, and two US sites (Irvine, California and Darien, Illinois), with founding entities including Shanghai OE Biotech Co. Ltd. Service offerings span sample preparation, cell capture, library construction, sequencing, and bioinformatics analysis across four technology platforms: 10x Genomics Chromium (with MobiDrop as a cost-effective alternative) for single-cell RNA sequencing and immune profiling; 10x Genomics Visium, Visium HD, and Xenium In Situ plus STOmics Stereo-seq for spatial transcriptomics; and custom cDNA expression library construction with yeast one-hybrid, two-hybrid, and curated family library screening (covering 500+ species with 500+ libraries built).

The business operates on a fee-for-service model with project-based, quote-driven pricing determined by sample type, target cell number, sequencing depth, platform selection, and customization, with multi-month contract cadences and a stated 4-week standard turnaround. Go-to-market combines direct enterprise sales through website quote requests, PhD-level technical consultation, and regional representatives with content marketing (publication showcase, technical blog, brochures), scientific conference presence (AACR, PAG33, EACR, ESHG), and social media engagement. As a Certified Service Provider for 10x Genomics with Stereo-seq data quality officially recognized by STOmics at the highest level, the company is differentiated by multi-platform certifications, proprietary workflows (e.g., FX-Cell for plant protoplasts), 12-step QC processes, and a validated track record supporting 5,000+ publications with cumulative impact factor approaching 40,000 across 2,800+ research institutions.

Customer concentration is dispersed across thousands of academic institutions as the primary segment, with secondary exposure to pharma/biotech translational research and plant science research. The company is privately held, no funding rounds or external institutional investment are disclosed, and revenue figures are not publicly available. Strategic moves in 2025-2026 include the July 2025 Hong Kong Science Park laboratory opening and the January 2026 Xenium In Situ Spatial Transcriptomics launch at that facility, signaling active geographic and product-line expansion in Asia-Pacific.

Name

Omics Empower

Legal name

Shanghai OE Biotech Co. Ltd

Website

https://omicsempower.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Omics Empower is a Singapore-headquartered global CRO providing end-to-end single-cell sequencing, spatial transcriptomics, and yeast library screening services to academic researchers, pharmaceutical companies, and plant science investigators, with laboratories in Germany, Hong Kong, and the United States operating across 10x Genomics, STOmics, and MobiDrop platforms.

Ownership category

akta.pro rank

Product category

Biotechnology Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Single-Cell & Spatial Omics Services (HLAGANAC)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF), Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF)

Keywords

• Single-cell sequencing services
• Spatial transcriptomics services
• Yeast library screening
• Biotechnology contract research
• Multi-omics CRO services

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Research Organization (CRO) Services: Omics Empower operates as a fee-for-service CRO, providing single-cell sequencing, spatial transcriptomics, and yeast library screening services to research institutions and pharmaceutical/biotech companies. Services are priced on a project-by-project basis depending on sample type, target cell number, sequencing depth, customization, and platform selected. Typical turnaround is 4 weeks for single-cell and spatial projects. The company has supported 5,000+ publications across 2,800+ research institutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Omics Empower is a global Contract Research Organization (CRO) that delivers end-to-end single-cell sequencing, spatial transcriptomics, and yeast hybrid library screening services to academic and pharmaceutical researchers. Services span the complete workflow from sample preparation, cell capture, and library construction through high-throughput sequencing (Illumina NovaSeq) and bioinformatics analysis, leveraging 10x Genomics (Chromium, Visium, Visium HD, Xenium), STOmics Stereo-seq, and MobiDrop platforms across laboratories in Germany, Hong Kong, and the United States.

Product overview

Omics Empower is a global CRO offering a integrated portfolio of single-cell sequencing, spatial transcriptomics, and yeast hybrid screening services. The core offerings are organized into three service lines: (1) Single-Cell Sequencing — comprising Single Cell RNA Sequencing and Single Cell Immune Profiling Service delivered on 10x Genomics Chromium and MobiDrop platforms; (2) Spatial Transcriptomics — comprising Visium Spatial Service, Xenium In Situ Service, and Stereo-seq Spatial Service, powered by 10x Genomics and STOmics technologies; and (3) Yeast Library — comprising Yeast Library Construction, Yeast One-Hybrid Screening Service, Yeast Two-Hybrid Screening, and Yeast Family Library Screening for protein/DNA interaction discovery. End-to-end workflows span sample preparation, cell capture, library construction, sequencing, and bioinformatics analysis, with labs in Germany, Hong Kong, and the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Single Cell RNA Sequencing scRNA-seq service using 10x Genomics Chromium and MobiDrop platforms, supporting 3' and 5' gene expression profiling for whole cells and nuclei, with end-to-end workflow from sample prep to bioinformatics.
• Single Cell Immune Profiling Service Integrates single-cell RNA sequencing with immune repertoire analysis to simultaneously characterize gene expression and paired TCR/BCR sequences at single-cell resolution, powered by droplet-based platforms.
• Visium Spatial Service 10x Genomics Visium and Visium HD spatial transcriptomics enabling whole-transcriptome profiling with tissue morphology preservation; Visium provides 55 µm spot resolution; Visium HD offers sub-cellular resolution for FFPE and fresh frozen samples.
• Xenium In Situ Service 10x Genomics Xenium in situ transcriptomics platform using multiplex imaging and decoding cycles for direct RNA detection in intact tissue at single-cell and subcellular resolution; supports FFPE and fresh-frozen samples with ready-to-use or custom panels (1–100 genes).
• Stereo-seq Spatial Service STOmics Stereo-seq spatial transcriptomics using DNA Nanoball (DNB) arrays offering ~500 nm resolution, large capture areas up to 13 × 13 cm, and sub-cellular gene expression mapping for fresh frozen and FFPE tissue.
• Yeast Library Construction Custom cDNA expression library construction using Gateway or SMART cloning methods for nuclear, membrane, and expression libraries, with 12-step quality control and support for Y1H and Y2H screening.
• Yeast One-Hybrid Screening Service Identifies transcription factors binding to target DNA sequences such as promoters or cis-regulatory elements using DNA-protein interaction assays in yeast, with high-throughput screening and follow-up clone support.
• Yeast Two-Hybrid Screening Protein-protein interaction detection using nuclear or membrane-based yeast hybrid systems via mating or co-transformation, with one-on-one verification and professional bioinformatics support.
• Yeast Family Library Screening Screens genes against curated transcription factor family libraries from Oryza sativa and Arabidopsis thaliana, plus a rice ubiquitin E3 library; with coverage rates over 80% for TFs and 98.94% for ubiquitin E3s.

Quantifiable outcome

• 4-week turnaround from sample receipt to data delivery for single-cell and spatial projects
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core, secondary and supporting.

• Professor Ning Yuese, Plant Protection Institute, Chinese Academy of Agricultural SciencescoreStrategic or Co-development Partner · 1 July 2022In July 2022, Omics Empower joined forces with Professor Ning Yuese to launch a rice ubiquitin E3 library for yeast two-hybrid screening, expanding the company's curated transcription factor and ubiquitin family screening services.
• 10x GenomicscoreTechnology or IntegrationOmics Empower is a Certified Service Provider of 10x Genomics, offering Chromium single-cell, Visium, Visium HD, and Xenium In Situ platforms. This partnership provides access to industry-leading spatial and single-cell technologies with standardized workflows and validated data quality. Omics Empower was the second facility in Hong Kong to operate the 10x Genomics Xenium platform.
• STOmicscoreTechnology or IntegrationOmics Empower provides Stereo-seq spatial transcriptomics services as a global CRO, using STOmics Stereo-seq technology based on DNA Nanoball (DNB) arrays. The company's Stereo-seq OMNI (FFPE) data quality has been officially recognized by STOmics at the highest level.
• MobiDropsecondaryTechnology or IntegrationOmics Empower offers single-cell sequencing services using the MobiDrop MobiNova 100 platform, a cost-effective droplet-based alternative to 10x Genomics, delivering comparable performance at up to 50% lower total project cost.
• Professor Chen Fan, Institute of Genetics, Chinese Academy of SciencescoreStrategic or Co-development PartnerIn 2018, Omics Empower joined forces with Professor Chen Fan to establish a rice transcription factor library, combining academic expertise with the company's yeast hybrid technology platform for plant research applications.
• Professor Qu Lijia, Peking UniversitycoreStrategic or Co-development PartnerIn 2018, Omics Empower collaborated with Professor Qu Lijia to launch the Arabidopsis transcription factor library screening service, leveraging the university's research expertise and the company's yeast library infrastructure.
• IlluminasupportingTechnology or IntegrationOmics Empower uses Illumina NovaSeq systems for sequencing, providing high-throughput sequencing capacity to support single-cell and spatial transcriptomics workflows.

Scale indicators13 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Novogene: Novogene is one of the world's largest genomics CROs providing sequencing, library prep, and bioinformatics services to academic and pharma researchers; it competes head-on with Omics Empower on next-generation sequencing projects and shares the same certified service-provider positioning with 10x Genomics.
• Azenta Life Sciences (formerly GENEWIZ): Azenta/GENEWIZ is a major genomics and next-generation sequencing CRO with global lab presence, offering Sanger, NGS, and increasingly single-cell services; it is directly comparable in customer model, service breadth, and global footprint.
• Singleron Biotechnologies: Singleron is a China-origin single-cell sequencing CRO offering end-to-end scRNA-seq services and instruments to academic and pharma customers globally; it directly overlaps with Omics Empower's core single-cell sequencing service line and target customer base in APAC and internationally.
• CD Genomics: CD Genomics is a US-based CRO specializing in sequencing services including single-cell and spatial transcriptomics; it competes with Omics Empower on similar technology platforms and serves the same academic and translational research customer base.

Emerging players

• Active Motif: Active Motif provides epigenomics, chromatin, and transcriptomics services and kits to research customers, with growing overlap into single-cell and spatial services; it is comparable as an emerging CRO peer in the omics-services market segment.
• Parse Biosciences: Parse Biosciences offers scalable single-cell RNA sequencing without microfluidic instrumentation, targeting customers seeking high-throughput, lower-cost alternatives; its technology approach overlaps with Omics Empower's MobiDrop cost-tier offering and competing service providers.

Regional players

• MedGenome: MedGenome is a leading genomics CRO primarily serving the South Asian market (India, SE Asia) with clinical and research sequencing services; it has limited overlap with Omics Empower on platform but competes in similar translational research services regionally.

Broad incumbents

• BGI Group: BGI is the world's largest genomics organization and the owner/developer of STOmics Stereo-seq technology, one of Omics Empower's core platforms; it competes both as a service provider and as an upstream technology vendor to the same research market.
• Eurofins Genomics: Eurofins Genomics is the genomics arm of Eurofins Scientific, a global life-sciences testing giant with broad sequencing, bioinformatics, and contract research offerings; it overlaps broadly with Omics Empower's services but operates at far greater scale and across many adjacent life-sciences segments.
• 10x Genomics: 10x Genomics is the developer of Chromium, Visium, and Xenium platforms and a Certified Service Provider partner of Omics Empower; while it primarily sells instruments and reagents, its 10x Services arm competes for the same single-cell and spatial transcriptomics service projects.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/omics_empower
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/omics-empower

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omics Empower